Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
6.14
-0.02 (-0.32%)
At close: Aug 1, 2025, 4:00 PM
6.17
+0.03 (0.49%)
After-hours: Aug 1, 2025, 4:04 PM EDT

Chimerix Stock Forecast

SLN's stock price has decreased by -70.05% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 5 analysts that cover Chimerix stock have a consensus rating of "Buy" and an average price target of $32.6, which forecasts a 430.94% increase in the stock price over the next year. The lowest target is $3.00 and the highest is $75.

Price Target: $32.60 (+430.94%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$3.00$32.6$25$75
Change-51.14%+430.94%+307.17%+1121.5%
* Price targets were last updated on Jun 13, 2025.

Analyst Ratings

The average analyst rating for Chimerix stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingFeb '25Mar '25Apr '25May '25Jun '25Jul '25
Strong Buy222222
Buy122222
Hold000000
Sell000000
Strong Sell111111
Total455555

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$75
Strong BuyReiterates$75+1,121.50%Jun 13, 2025
Chardan Capital
Chardan Capital
Strong Buy
Maintains
$35
Strong BuyMaintains$35+470.03%Jun 13, 2025
Goldman Sachs
Goldman Sachs
Strong Sell
Maintains
$4$3
Strong SellMaintains$4$3-51.14%May 9, 2025
Morgan Stanley
Morgan Stanley
Buy
Maintains
$45$25
BuyMaintains$45$25+307.17%May 9, 2025
Chardan Capital
Chardan Capital
Strong Buy
Maintains
$55$35
Strong BuyMaintains$55$35+470.03%May 9, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
32.34M
from 43.26M
Decreased by -25.23%
Revenue Next Year
n/a
from 32.34M
EPS This Year
n/a
from -0.98
EPS Next Year
n/a
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025
Revenue
7.48M16.81M21.66M31.64M43.26M32.34M
Revenue Growth
2,214.81%124.73%28.82%46.12%36.71%-25.23%
EPS
-1.63-1.80-1.56-1.46-0.98-
EPS Growth
------
Forward PE
------
No. Analysts
-----6
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue2025
High74.5M
Avg32.3M
Low10.3M

Revenue Growth

Revenue Growth2025
High
72.2%
Avg
-25.2%
Low
-76.3%

EPS Forecast

EPS
High
Avg
Low

EPS Growth

EPS Growth
High
Avg
Low
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.